Laboratorios Farmaceuticos Rovi, S.A. (0ILL.L) LSE

70.25

+0.15(+0.21%)

Updated at January 15 05:36PM

Currency In EUR

Valuation

Market Cap3.21B
Enterprise Value3.31B
P/E Ratio29.57
PEG Ratio-6.75
Price/Sales Ratio4.95
Price/Book Ratio5.76
Enterprise/Revenue5.05
Enterprise/EBITDA19.29

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.17
Operating Margin0.22

Management Effectiveness

Return On Assets0.13
Return On Equity0.21

Income Statement

Revenue763.75M
Revenue/Share14.16
Gross Profit449.68M
EBITDA208.2M
Net Income136.88M
Diluted EPS2.68

Balance Sheet

Total Cash49.25M
Total Cash/Share0.96
Total Debt123.62M
Total Debt/Equity0.2
Current Ratio3.02
Book Value Per Share12.37

Price History

52-Week Change18.57
52-Week High79.76
52-Week Low37.14
Moving Average 50 Days67.54
Moving Average 200 Days53.85

Statistics

Average Volume11,270
Shares Outstanding51.15M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.94
Trailing Annual Dividend Yield1.33
Payout Ratio0.39
Last Split FactorN/A
Last Split DateN/A